Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Twist Bioscience Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
TWST
Nasdaq
2836
www.twistbioscience.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Twist Bioscience Corporation
Cathie Wood Is Buying the CoreWeave Dip and Selling Palantir
- Nov 13th, 2026 7:37 am
Twist Bioscience Corporation Q4 2026 Earnings Call Summary
- Nov 12th, 2026 3:15 pm
This Biotech's Guidance Seemingly Beat Expectations — But A Twist Slammed The Stock
- Nov 12th, 2026 2:16 pm
Twist Bioscience Q4 Earnings Call Highlights
- Nov 12th, 2026 2:14 pm
Twist Bioscience: 3 Key Takeaways for Long-Term Investors
- Nov 12th, 2026 2:09 pm
Twist Bioscience earnings analysis: questions answered and next catalysts
- Nov 12th, 2026 1:59 pm
Twist Bioscience (TWST) Q4 2026 Earnings Call Transcript
- Nov 12th, 2026 12:45 pm
Full-Year Revenue Guidance and Strong Quarter Drove Twist Bioscience Corporation (TWST) Higher in Q3
- Nov 12th, 2026 8:07 am
Twist Bioscience: Fiscal Q4 Earnings Snapshot
- Nov 12th, 2026 6:40 am
Twist Bioscience (TWST) Reports Q4 Loss, Beats Revenue Estimates
- Nov 12th, 2026 6:35 am
Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
- Nov 12th, 2026 5:15 am
Twist Bioscience Stock Has The Bull Case Changed After MRD Panel Launch?
- Nov 12th, 2026 1:11 am
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Nov 11th, 2026 6:00 am
Twist Bioscience to Present at Upcoming Investor Conferences
- Nov 9th, 2026 6:00 am
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates
- Nov 9th, 2026 5:40 am
ANI Pharmaceuticals (ANIP) Surpasses Q3 Earnings and Revenue Estimates
- Nov 5th, 2026 5:15 am
Bloom Energy (BE) Raises Full-Year Outlook Following 166% Revenue Surge
- Nov 4th, 2026 8:26 am
Argan (AGX) Shares Fall After Record Q2 Earnings as Backlog Dips to $2.5 Billion
- Nov 4th, 2026 8:24 am
Notice of Proposed Derivative Settlement: Twist Bioscience Corporation
- Nov 3rd, 2026 2:05 pm
Beam Therapeutics Inc. (BEAM) Reports Q3 Loss, Misses Revenue Estimates
- Nov 3rd, 2026 5:15 am
Scroll